Vifor Pharma Ltd - Strategy, SWOT and Corporate Finance Report
Vifor Pharma Ltd - Strategy, SWOT and Corporate Finance Report
SUMMARY
Vifor Pharma Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
KEY HIGHLIGHTS
Vifor Pharma Ltd (Vifor Pharma) focuses on discovery, development, and marketing of prescription medicines and non-prescription drugs. The company offers intravenous pharmaceuticals for iron deficiency, besides products for nephrology and cardio-renal therapies. It also provides pharmaceuticals for the treatment of respiratory tract infections, ear care, abdominal distension, chronic obstructive pulmonary disease, hemorrhoids, chronic venous insufficiency, diabetic retinopathy, lower urinary tract infections, menometrorrhagia, chronic kidney disease, and hyperkalemia. Vifor Pharma also discovers, develops, and markets polymeric medicines for unmet medical needs of the gastrointestinal tract. It operates production plants in Portugal and Switzerland, and carries out business through subsidiaries. Vifor Pharma is headquartered in St. Gallen, Switzerland
SCOPE
SUMMARY
Vifor Pharma Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
KEY HIGHLIGHTS
Vifor Pharma Ltd (Vifor Pharma) focuses on discovery, development, and marketing of prescription medicines and non-prescription drugs. The company offers intravenous pharmaceuticals for iron deficiency, besides products for nephrology and cardio-renal therapies. It also provides pharmaceuticals for the treatment of respiratory tract infections, ear care, abdominal distension, chronic obstructive pulmonary disease, hemorrhoids, chronic venous insufficiency, diabetic retinopathy, lower urinary tract infections, menometrorrhagia, chronic kidney disease, and hyperkalemia. Vifor Pharma also discovers, develops, and markets polymeric medicines for unmet medical needs of the gastrointestinal tract. It operates production plants in Portugal and Switzerland, and carries out business through subsidiaries. Vifor Pharma is headquartered in St. Gallen, Switzerland
SCOPE
- Detailed information on Vifor Pharma Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vifor Pharma Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Vifor Pharma Ltd including a breakdown and examination of key business segments
- Intelligence on Vifor Pharma Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vifor Pharma Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Vifor Pharma Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vifor Pharma Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Vifor Pharma Ltd's business structure, strategy and prospects.
Company Snapshot
Vifor Pharma Ltd: Company Overview
Vifor Pharma Ltd: Overview and Key Facts
Vifor Pharma Ltd: Overview
Vifor Pharma Ltd: Key Facts
Vifor Pharma Ltd: Key Employees
Vifor Pharma Ltd: Key Employee Biographies
Vifor Pharma Ltd: Major Products and Services
Vifor Pharma Ltd: Company History
Vifor Pharma Ltd: Management Statement
Vifor Pharma Ltd: Locations and Subsidiaries
Vifor Pharma Ltd: Key Competitors
Vifor Pharma Ltd: Company Analysis
Vifor Pharma Ltd: Business Description
Vifor Pharma Ltd: SWOT Analysis
Vifor Pharma Ltd: SWOT Overview
Vifor Pharma Ltd: Strengths
Vifor Pharma Ltd: Weaknesses
Vifor Pharma Ltd: Opportunities
Vifor Pharma Ltd: Threats
Vifor Pharma Ltd: Corporate Financial Deals Activity
Vifor Pharma Ltd: Financial Deals Overview
Vifor Pharma Ltd: Targets and Partners
Vifor Pharma Ltd: Top Deals 2018 - 2022YTD*
Vifor Pharma Ltd: Advisors
Vifor Pharma Ltd: Top Legal Advisors
Vifor Pharma Ltd: Top Financial Advisors
Vifor Pharma Ltd: Mergers and Acquisitions
Vifor Pharma Ltd: Partnership
Vifor Pharma Ltd: Divestments
Vifor Pharma Ltd: Private Equity and Ownership
Vifor Pharma Ltd: Recent Developments
Vifor Pharma Ltd: News and Events Summary
Vifor Pharma Ltd: Business Expansion
Vifor Pharma Ltd: Contracts
Vifor Pharma Ltd: Corporate Governance
Vifor Pharma Ltd: Financial Performance
Vifor Pharma Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
Vifor Pharma Ltd: Company Overview
Vifor Pharma Ltd: Overview and Key Facts
Vifor Pharma Ltd: Overview
Vifor Pharma Ltd: Key Facts
Vifor Pharma Ltd: Key Employees
Vifor Pharma Ltd: Key Employee Biographies
Vifor Pharma Ltd: Major Products and Services
Vifor Pharma Ltd: Company History
Vifor Pharma Ltd: Management Statement
Vifor Pharma Ltd: Locations and Subsidiaries
Vifor Pharma Ltd: Key Competitors
Vifor Pharma Ltd: Company Analysis
Vifor Pharma Ltd: Business Description
Vifor Pharma Ltd: SWOT Analysis
Vifor Pharma Ltd: SWOT Overview
Vifor Pharma Ltd: Strengths
Vifor Pharma Ltd: Weaknesses
Vifor Pharma Ltd: Opportunities
Vifor Pharma Ltd: Threats
Vifor Pharma Ltd: Corporate Financial Deals Activity
Vifor Pharma Ltd: Financial Deals Overview
Vifor Pharma Ltd: Targets and Partners
Vifor Pharma Ltd: Top Deals 2018 - 2022YTD*
Vifor Pharma Ltd: Advisors
Vifor Pharma Ltd: Top Legal Advisors
Vifor Pharma Ltd: Top Financial Advisors
Vifor Pharma Ltd: Mergers and Acquisitions
Vifor Pharma Ltd: Partnership
Vifor Pharma Ltd: Divestments
Vifor Pharma Ltd: Private Equity and Ownership
Vifor Pharma Ltd: Recent Developments
Vifor Pharma Ltd: News and Events Summary
Vifor Pharma Ltd: Business Expansion
Vifor Pharma Ltd: Contracts
Vifor Pharma Ltd: Corporate Governance
Vifor Pharma Ltd: Financial Performance
Vifor Pharma Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES
Table 1: Vifor Pharma Ltd: Key Facts
Table 2: Vifor Pharma Ltd: Key Employees
Table 3: Vifor Pharma Ltd: Company History
Table 4: Vifor Pharma Ltd: Locations and Subsidiaries
Table 5: Vifor Pharma Ltd: Key Competitors
Table 6: Vifor Pharma Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Vifor Pharma Ltd: M&A Activity by Geography (TTM*)
Table 8: Vifor Pharma Ltd: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 9: Vifor Pharma Ltd: M&A Average Deal Size - Value (US$m)
Table 10: Vifor Pharma Ltd: Targets and Partners
Table 11: Vifor Pharma Ltd: Top Deals 2018 - 2022YTD*
Table 12: Vifor Pharma Ltd: Legal Advisor Ranking by Value (US$m)
Table 13: Vifor Pharma Ltd: Financial Advisor Ranking by Value (US$m)
Table 14: Vifor Pharma Ltd: M&A Volume and Value Trend (2018 - YTD*2022)
Table 15: Vifor Pharma Ltd: M&A Activity by Geography (2018 - YTD*2022)
Table 16: Vifor Pharma Ltd: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 17: Vifor Pharma Ltd: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 18: Vifor Pharma Ltd: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 19: Vifor Pharma Ltd: Divestments by Geography (2018 - YTD*2022)
Table 20: Vifor Pharma Ltd: Private Equity and Ownership Volume and Value Trend (2018 - YTD*2022)
Table 21: Vifor Pharma Ltd: Private Equity and Ownership Volume by Deal Type (2018 - YTD*2022)
Table 22: Vifor Pharma Ltd: News and Events Summary
Table 23: Vifor Pharma Ltd: Business Expansion
Table 24: Vifor Pharma Ltd: Contracts
Table 25: Vifor Pharma Ltd: Corporate Governance
Table 26: Vifor Pharma Ltd: Financial Performance
Table 27: Vifor Pharma Ltd: Strategy and Operations
Table 1: Vifor Pharma Ltd: Key Facts
Table 2: Vifor Pharma Ltd: Key Employees
Table 3: Vifor Pharma Ltd: Company History
Table 4: Vifor Pharma Ltd: Locations and Subsidiaries
Table 5: Vifor Pharma Ltd: Key Competitors
Table 6: Vifor Pharma Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Vifor Pharma Ltd: M&A Activity by Geography (TTM*)
Table 8: Vifor Pharma Ltd: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 9: Vifor Pharma Ltd: M&A Average Deal Size - Value (US$m)
Table 10: Vifor Pharma Ltd: Targets and Partners
Table 11: Vifor Pharma Ltd: Top Deals 2018 - 2022YTD*
Table 12: Vifor Pharma Ltd: Legal Advisor Ranking by Value (US$m)
Table 13: Vifor Pharma Ltd: Financial Advisor Ranking by Value (US$m)
Table 14: Vifor Pharma Ltd: M&A Volume and Value Trend (2018 - YTD*2022)
Table 15: Vifor Pharma Ltd: M&A Activity by Geography (2018 - YTD*2022)
Table 16: Vifor Pharma Ltd: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 17: Vifor Pharma Ltd: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 18: Vifor Pharma Ltd: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 19: Vifor Pharma Ltd: Divestments by Geography (2018 - YTD*2022)
Table 20: Vifor Pharma Ltd: Private Equity and Ownership Volume and Value Trend (2018 - YTD*2022)
Table 21: Vifor Pharma Ltd: Private Equity and Ownership Volume by Deal Type (2018 - YTD*2022)
Table 22: Vifor Pharma Ltd: News and Events Summary
Table 23: Vifor Pharma Ltd: Business Expansion
Table 24: Vifor Pharma Ltd: Contracts
Table 25: Vifor Pharma Ltd: Corporate Governance
Table 26: Vifor Pharma Ltd: Financial Performance
Table 27: Vifor Pharma Ltd: Strategy and Operations
LIST OF FIGURES
Figure 1: Vifor Pharma Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vifor Pharma Ltd: M&A Activity by Geography (TTM*)
Figure 3: Vifor Pharma Ltd: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 4: Vifor Pharma Ltd: M&A Average Deal Size - Value (US$m)
Figure 5: Vifor Pharma Ltd: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 6: Vifor Pharma Ltd: M&A Activity by Geography (2018 - YTD*2022)
Figure 7: Vifor Pharma Ltd: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 8: Vifor Pharma Ltd: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 9: Vifor Pharma Ltd: Divestments Volume and Value Trend (2018 - YTD*2022)
Figure 10: Vifor Pharma Ltd: Divestments by Geography (2018 - YTD*2022)
Figure 11: Vifor Pharma Ltd: Private Equity and Ownership Volume and Value Trend (2018 - YTD*2022)
Figure 12: Vifor Pharma Ltd: Private Equity and Ownership Volume by Deal Type (2018 - YTD*2022)
Figure 1: Vifor Pharma Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vifor Pharma Ltd: M&A Activity by Geography (TTM*)
Figure 3: Vifor Pharma Ltd: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 4: Vifor Pharma Ltd: M&A Average Deal Size - Value (US$m)
Figure 5: Vifor Pharma Ltd: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 6: Vifor Pharma Ltd: M&A Activity by Geography (2018 - YTD*2022)
Figure 7: Vifor Pharma Ltd: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 8: Vifor Pharma Ltd: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 9: Vifor Pharma Ltd: Divestments Volume and Value Trend (2018 - YTD*2022)
Figure 10: Vifor Pharma Ltd: Divestments by Geography (2018 - YTD*2022)
Figure 11: Vifor Pharma Ltd: Private Equity and Ownership Volume and Value Trend (2018 - YTD*2022)
Figure 12: Vifor Pharma Ltd: Private Equity and Ownership Volume by Deal Type (2018 - YTD*2022)
